Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1619-7089

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease ; day:2 ; month:2 ; year:2018 ; pages:1-10
European journal of nuclear medicine and molecular imaging ; (2.2.2018), 1-10

Keyword: Diagnose
Diagnostik
Differentialdiagnose
Pflegediagnose

Contributor: Pascoal, Tharick A.
Mathotaarachchi, Sulantha
Shin, Monica
Park, Ah Yeon
Mohades, Sara
Benedet, Andrea L.
Kang, Min Su
Massarweh, Gassan
Soucy, Jean-Paul
Gauthier, Serge
Rosa-Neto, Pedro
SpringerLink (Online service)

DOI: 10.1007/s00259-018-3933-3

URN: urn:nbn:de:1111-20180330411

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:54 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Pascoal, Tharick A.
Mathotaarachchi, Sulantha
Shin, Monica
Park, Ah Yeon
Mohades, Sara
Benedet, Andrea L.
Kang, Min Su
Massarweh, Gassan
Soucy, Jean-Paul
Gauthier, Serge
Rosa-Neto, Pedro
SpringerLink (Online service)

Other Objects (12)

Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease

APOE effects on regional tau in preclinical Alzheimer’s disease

Visual short-term memory relates to tau and amyloid burdens in preclinical autosomal dominant Alzheimer’s disease

Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease

Inter-network connectivity and amyloid-beta linked to cognitive decline in preclinical Alzheimer’s disease: a longitudinal cohort study

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers

Views and Perceptions of Amyloid Imaging in a Preclinical Alzheimer’s Disease Trial

Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease

Left Frontoparietal Control Network Connectivity Moderates the Effect of Amyloid on Cognitive Decline in Preclinical Alzheimer’s Disease: The A4 Study

Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease

APOE effects on regional tau in preclinical Alzheimer’s disease

Visual short-term memory relates to tau and amyloid burdens in preclinical autosomal dominant Alzheimer’s disease

Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease

Inter-network connectivity and amyloid-beta linked to cognitive decline in preclinical Alzheimer’s disease: a longitudinal cohort study

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers

Views and Perceptions of Amyloid Imaging in a Preclinical Alzheimer’s Disease Trial

Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease

Left Frontoparietal Control Network Connectivity Moderates the Effect of Amyloid on Cognitive Decline in Preclinical Alzheimer’s Disease: The A4 Study

Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease

APOE effects on regional tau in preclinical Alzheimer’s disease

Visual short-term memory relates to tau and amyloid burdens in preclinical autosomal dominant Alzheimer’s disease

Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease

Inter-network connectivity and amyloid-beta linked to cognitive decline in preclinical Alzheimer’s disease: a longitudinal cohort study

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers

Views and Perceptions of Amyloid Imaging in a Preclinical Alzheimer’s Disease Trial

Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease

Left Frontoparietal Control Network Connectivity Moderates the Effect of Amyloid on Cognitive Decline in Preclinical Alzheimer’s Disease: The A4 Study

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease

APOE effects on regional tau in preclinical Alzheimer’s disease

Visual short-term memory relates to tau and amyloid burdens in preclinical autosomal dominant Alzheimer’s disease

Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease

Inter-network connectivity and amyloid-beta linked to cognitive decline in preclinical Alzheimer’s disease: a longitudinal cohort study

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers

Views and Perceptions of Amyloid Imaging in a Preclinical Alzheimer’s Disease Trial

Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease

Left Frontoparietal Control Network Connectivity Moderates the Effect of Amyloid on Cognitive Decline in Preclinical Alzheimer’s Disease: The A4 Study

Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease

APOE effects on regional tau in preclinical Alzheimer’s disease

Visual short-term memory relates to tau and amyloid burdens in preclinical autosomal dominant Alzheimer’s disease

Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease

Inter-network connectivity and amyloid-beta linked to cognitive decline in preclinical Alzheimer’s disease: a longitudinal cohort study

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers

Views and Perceptions of Amyloid Imaging in a Preclinical Alzheimer’s Disease Trial

Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease

Left Frontoparietal Control Network Connectivity Moderates the Effect of Amyloid on Cognitive Decline in Preclinical Alzheimer’s Disease: The A4 Study

Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease

APOE effects on regional tau in preclinical Alzheimer’s disease

Visual short-term memory relates to tau and amyloid burdens in preclinical autosomal dominant Alzheimer’s disease

Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease

Inter-network connectivity and amyloid-beta linked to cognitive decline in preclinical Alzheimer’s disease: a longitudinal cohort study

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers

Views and Perceptions of Amyloid Imaging in a Preclinical Alzheimer’s Disease Trial

Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease

Left Frontoparietal Control Network Connectivity Moderates the Effect of Amyloid on Cognitive Decline in Preclinical Alzheimer’s Disease: The A4 Study

Related objects

Reset password